Complications of chronic use of skin lightening cosmetics
Yetunde M. Olumide MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorAyesha O. Akinkugbe MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorDan Altraide MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorTahir Mohammed MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorNgozi Ahamefule MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorShola Ayanlowo MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorChinwe Onyekonwu MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorNyomudim Essen MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorYetunde M. Olumide MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorAyesha O. Akinkugbe MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorDan Altraide MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorTahir Mohammed MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorNgozi Ahamefule MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorShola Ayanlowo MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorChinwe Onyekonwu MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorNyomudim Essen MD
From the Dermatology Unit, epartment of Medicine, College of Medicine, Lagos, Nigeria
Search for more papers by this authorAbstract
Skin lightening (bleaching) cosmetics and toiletries are widely used in most African countries. The active ingredients in these cosmetic products are hydroquinone, mercury and corticosteroids. Several additives (conconctions) are used to enhance the bleaching effect. Since these products are used for long duration, on a large body surface area, and under hot humid conditions, percutaneous absorption is enhanced. The complications of these products are very serious and are sometimes fatal. Some of these complications are exogenous ochronosis, impaired wound healing and wound dehiscence, the fish odor syndrome, nephropathy, steroid addiction syndrome, predisposition to infections, a broad spectrum of cutaneous and endocrinologic complications of corticosteroids, including suppression of hypothalamic-pituitary-adrenal axis. In this era of easy travels and migration, African patients with these complications can present to physicians anywhere in the world. It is therefore critical for every practicing physician to be aware of these complications.
References
- 1 Barr RD, Rees PH, Cordy PE, et al . Nephrotic Syndrome in Adult Africans in Nairobi. Br Med J 1972; 2: 131–134.
- 2 Addo HA. A Clinical study of hydroquinone reaction in skin bleaching in Ghana. Ghana Med J 1992; 26: 448–453.
- 3 Findlay GH, Morrison JGL, Simson IW. Exogenous ochronosis and pigmented colloid millium from hydroquinone bleaching creams. Brit J Dermatol 1975; 613–622.
- 4 Hardwick N, Van Gelder LW, Van Der Merwe CA, et al . Exogenous ochronosis in an epidemiological study. Br J Dermatol 1989; 120: 229–238.
- 5 Muchadeyi E, Thompson S, Baker N. A Survey of the constituents, availability and use of the skin lightening creams in Zimbabwe. Cent Afr J Med 1982; 29: 225–227.
- 6 Cullison D, Abelle DC, O’Quinn JL. Localised exogenous ochronosis. J Am Acad Dermatol 1983; 8: 882–889.
- 7 Hoshaw RA, Zimmerman KG, Menter A. Ochronosis-like Pigmentation from Hydroquinone. Arch Dermatol 1985; 121: 105–108.
- 8 Boyle J, Kennedy CTC. British Cosmetic regulations inadequate. Br Medical J 1984; 288–299.
- 9 Oliveira DGB, Foster G, Savill J, et al . Membranous Nephropathy caused by mercury-containing skin lightening cream. Postgrad Med J 1989; 63: 303–304.
- 10 Beddard AP, Plumtre CM. A further note on ochronosis associated with carboluria. Quart J Med 1912; 5: 505–507.
- 11 Addo HA. Squamous cell cancinoma associated with prolonged bleaching. Ghana Med J 2000; 34: 3.
- 12 Mahe A, Keita S, Bobin P. Dermatologic complications of the cosmetic use of bleaching agents in Bamako (Mali). Ann Dermatol Venereol 1994; 121: 142–146.
- 13 Otto M, Ahlemeyer C, Tasche H, et al . Endemic mercury burden caused by a bleaching ointment in Balken refugees. Gesundheitswesen 1994; 56: 686–689.
- 14 Pick L. Uber die Ochronose. Klin Wochenschr 1906; 43: 478–480.
- 15 Snider RL, Thiers BH. Exogenous ochronosis. J Am Acad Dermatol 1993; 28: 662–664.
- 16 Diven DG, Smith EB, Pupo RA, et al . Hydroquinone-induced localized exogenous ochronosis treated with dermabrasion and CO2 laser. J Dermatol Surg Oncol 1990; 16: 1018–1022.
- 17 Ridley CM, Adams SJ. British cosmetic regulations inadequate. Br Med J 1984; 288: 1537.
- 18 Tidman MJ, Horton JJ, MacDonald DM. Hydroquinone-induced ochronosis – light and electron-microscopic features. Clin Exp Dermatol 1986; 11: 224–228.
- 19 Hoshaw RA, Zimmerman KG, Menter A. Ochronosislike pigmentation from hydroquinone bleaching creams in American blacks. Arch Dermatol 1985; 121: 105–108.
- 20 Lawrence N, Reed R, Perret WJ, et al . Exogenous ochronosis in the United States. J Am Acad Dermatol 1988; 18: 1207–1222.
- 21 Brauer EW. Safety of over-the-counter hydroquinone bleaching creams. [letter]. Arch Dermatol 1985; 121: 1239.
- 22 Boyle J, Kennedy CTC. Hydroquinone concentrations in skin lightening creams. Br J Derm 1986; 114: 502–504.
- 23 Olumide YM. Cosmetic Hazards and Legislative Needs in Nigeria. Nig Med Prac 1985; 9: 7–12.
- 24 Olumide YM. Abuse of Topical corticosteroids in Nigeria. Nig. Med. Pract 1986; 11: 17–12.
- 25 Olumide YM, Elesha SO. Hydroquinone induced exogenous ochronosis. Nig Med Pract 1986; 11: 103–106.
- 26 Olumide YM. Photodermatoses in Lagos. Int J Dermatol 1987; 26: 295–299.
- 27 Olumide YM. Contact leukoderma. Nig Quart J Hosp Medical 1989; 4: 53–62.
- 28 Olumide YM. A Pictorial Self-Instructional Manual on Common Skin Diseases. Nigeria: Heinemann Ibadan, 1990.
- 29 Olumide YM, Odunowo BD, Odiase AO. Regional dermatoses in the African I. Facial hypermelanosis. Int J Dermatol 1991; 30: 186–189.
- 30 Cosmetic Product Regulations (Prohibition of bleaching agents etc). Extraordinary Federal Republic Nigeria Official Gazette 1995; 82 (31c).
- 31 Olumide YM. Cosmetic habits and Legislative need in Nigeria. Paper presented at NAFDAC Workshop on “Cosmetics Safety Issues”, 2002.
- 32 Adebajo SB. An Epidemiological Survey of the Use of Cosmetic Skin Lightening Cosmetics among Traders in Lagos. Nigeria. Personal Communication.
- 33 Ofondu EO. Cosmetic use of bleaching creams in Enugu. Nigerian FMCP Dissertation, 2003.
- 34 Lerner AB, Fitzpatrick TB. Inhibition of melanin formation by chemical agents. J Invest Dermatol 1952; 18: 119–135.
- 35 Jimbow K, Obata H, Pathak MA, et al . Mechanism of Depigmentation by Hydroquinone. J Invest Dermatol 1974; 62: 436.
- 36 Findlay GH. Ochronosis following skin bleaching with hydroquinone (Editorial). J Am Acad Dermatol 1982; 6: 1092–1093.
- 37 Goldsmith LA. Cutaneous changes in errors of amino acid metabolism: alkaptonuria. In: TB Fitzpatrick, AZ Eisen, K Wolff, IM Freedberg, KF Austen, eds. Dermatology in General Medicine, Chap 148. New York: McGraw-Hill, 1993: 1841–1845.
- 38 Jackyk WK. Annular granulomatous lesions in exogenous ochronosis are manifestations of sarcoidosis. Am J Dermatopathol 1995; 17: 18–22.
- 39 Jordaan HF, Van Niekerk DJT. Transepidermal elimination in exogenous ochronosis. Am J Dermatopathol 1991; 13: 418–424.
- 40 Connor T, Braunstein B. Off-center fold: hyperpgimentation following the use of bleaching creams: localized exogenous ochronosis. Arch Dermatol 1987; 123: 105–106.
- 41 Ruocco V, Florio M. Fish-odor syndrome: an olfactory diagnosis. Int J Dermatol 1995; 34: 92–93.
- 42 Attwood HD, Clifton S, Mitchell RE, et al . A histological, histochemical and ultrastructural study of dermal ochronosis. Pathology (Phila) 1971; 3: 115.
- 43 Tidman MJ, Horton JJ, Macdonald DM, et al . Hydroquinone-induced ochronosis: Light and electron-microscopic features. Clin Exp Dermatol 1986; 11: 224.
- 44 Zannoni VG, Lomtevas N, Goldfinger S, et al . Oxidation of homogentisic acid to ochronotic pigment in connective tissue. Biochem Biophys Acta 1969; 177: 94.
- 45 Penneys ND. Ochronosislike pigmentation from hydroquinone bleaching creams. [letter]. Arch Dermatol 1985; 121: 1239.
- 46 Phillips JI, Isaacson C, Carman H. Ochronosis in black South Africans who used skin lighteners. Am J Dermatopathol 1986; 8: 14–21.
- 47 Hull PR, Procter PR. The melanocyte: An essential link in hydroquinone induced ochronosis. J Am Acad Dermatol 1990; 22: 529–531.
- 48 Dogliotte M, Liebowitz M. Granulomatous ochronosis – a cosmetic-induced skin disorder in blacks. S Afr Med J 1979; 56: 757–760.
- 49 Kramer KE, Lopez A, Stefanato CM, et al . Exogenous ochronosis. J Am Acad Dermatol 2000; 42: 869–871.
- 50 Cole HN, Schreider N, Sollman J. Mercurial ointments in the treatment of syphilis. Arch Dermatol 1930; 21: 372.
- 51
Alexander A,
Mendel K.
Chronishe Quecksilbervertifang durch langdauernden Gebrauch einer Sommersprossen-salbe.
Deutsh Med Wschr
1923; 49: 1021.
10.1055/s-0028-1132325 Google Scholar
- 52 Silverberg DS, McCall JT, Hunt JC. Nephrotic syndrome with use of ammoniated mercury. Arch Intern Med 1967; 120: 583–585.
- 53 Wealtherall DJ, Ledingham JGG, Warrell DA. Chemical and physical injuries. Climatic and occupational diseases. Oxford Textbook of Medicine 1985; 6.13–6.14.
- 54
Goeckermann WH.
A peculiar discolouration of the skin.
JAMA
1975; 84: 506–507.
10.1001/jama.1925.26620330001011 Google Scholar
- 55 Meymandi S, Wiseman MC, Crawford RI. Tinea faciei mimicking cutaneous lupus erythematosus: a histopathologic case report. J Am Acad Dermatol 2003; 48: S7–S8.
- 56 Singh R, Bharu K, Ghazali W, et al . Tinea faciei mimicking lupus erythematosus. Cutis 1994; 53: 297–298.
- 57 Lee SJ, Choi HJ, Hann SK. Rosacea-like tinea faciei. Int J Dermatol 1999; 38: 479–480.
- 58 Lutz ME, Gibson LE, El-Azhary RA, et al . Allergic contact dermatitis to topical application of corticosteroids. Mayo Clin Proc 1997; 72: 1141.